The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1/2 study of forodesine in patients with relapsed peripheral t-cell lymphoma (PTCL).
 
Kunihiro Tsukasaki
Honoraria - Chugai Pharma; HUYA Bioscience International; Zenyaku Kogyo
Research Funding - Celgene (Inst); Mundipharma (Inst); Takeda (Inst)
 
Kensei Tobinai
Honoraria - Eisai; Mundipharma; Spectrum Pharmaceuticals; Takeda; Zenyaku Kogyo
Research Funding - Abbvie (Inst); Celgene (Inst); Chugai Pharma (Inst); Eisai (Inst); GlaxoSmithKline (Inst); Janssen (Inst); Kyowa Hakko Kirin (Inst); Mundipharma (Inst); Ono Pharmaceutical (Inst); SERVIER (Inst); Takeda (Inst)
 
Toshiki Uchida
No Relationships to Disclose
 
Yoshinobu Maeda
No Relationships to Disclose
 
Hirohiko Shibayama
No Relationships to Disclose
 
Hirokazu Nagai
Honoraria - Chugai Pharma; Eisai; Kyowa Hakko Kirin; Sanofi; SymBio Pharmaceuticals; Takeda
Research Funding - Abbvie (Inst); Chugai Pharma (Inst); CMIC (Inst); Dainippon Sumitomo Pharma (Inst); Eisai (Inst); Janssen (Inst); Kyowa Hakko Kirin (Inst); Mundipharma (Inst); Ono Pharmaceutical (Inst); Otsuka (Inst); SERVIER (Inst); Solasia Pharma (Inst); Takeda (Inst)
 
Mitsutoshi Kurosawa
No Relationships to Disclose
 
Yasunobu Abe
No Relationships to Disclose
 
Kiyohiko Hatake
Honoraria - Kyowa Hakko Kirin
Research Funding - Celgene; Chugai Pharma; Kyowa Hakko Kirin; Ono Pharmaceutical; Takeda
 
Kiyoshi Ando
Research Funding - JSK Therapeutics (Inst); Kyowa Hakko Kirin (Inst)
 
Isao Yoshida
Honoraria - Celgene; Fujifilm; Kyowa Hakko Kirin; Mundipharma; Ono Pharmaceutical
Research Funding - Chugai Pharma (Inst); Kyowa Hakko Kirin (Inst)
 
Michihiro Hidaka
No Relationships to Disclose
 
Tohru Murayama
No Relationships to Disclose
 
Yoko Okitsu
No Relationships to Disclose
 
Norifumi Tsukamoto
No Relationships to Disclose
 
Masafumi Taniwaki
No Relationships to Disclose
 
Junji Suzumiya
Stock and Other Ownership Interests - Celgene
Consulting or Advisory Role - Zenyaku Kogyo
Research Funding - Chugai Pharma (Inst); Eisai (Inst); Kyowa Hakko Kirin (Inst); Takeda (Inst)
 
Kazuo Tamura
Consulting or Advisory Role - Lilly; Teijin Pharma; Teva
 
Takahiro Yamauchi
No Relationships to Disclose
 
Ryuzo Ueda
Leadership - TERUMO
Honoraria - Chugai Pharma; Kyowa Hakko Kirin; Ono Pharmaceutical
Consulting or Advisory Role - Mundipharma; Ono Pharmaceutical
Research Funding - Chugai Pharma (Inst); Kyowa Hakko Kirin (Inst); Medical & Biological Laboratories (Inst); Rikaken (Inst)